Koninklijke Philips Other Operating Income or Expenses 2010-2024 | PHG

Koninklijke Philips annual/quarterly other operating income or expenses history and growth rate from 2010 to 2024. Other operating income or expenses can be defined as the aggregate amount of all operating expenses either too small to report separately or that cannot be standardized into another Zacks field.
  • Koninklijke Philips other operating income or expenses for the quarter ending September 30, 2024 were $-0.010B, a 135.77% decline year-over-year.
  • Koninklijke Philips other operating income or expenses for the twelve months ending September 30, 2024 were $-0.052B, a 154.71% decline year-over-year.
  • Koninklijke Philips annual other operating income or expenses for 2024 were $-0.464B, a 19.53% decline from 2023.
  • Koninklijke Philips annual other operating income or expenses for 2023 were $-0.577B, a 3141.74% decline from 2022.
  • Koninklijke Philips annual other operating income or expenses for 2022 were $0.019B, a 66.6% decline from 2021.
Koninklijke Philips Annual Other Operating Income or Expenses
(Millions of US $)
2024 $-464
2023 $-577
2022 $19
2021 $57
2020 $-57
2019 $-37
2018 $65
2017 $86
2016 $30
2015 $97
2014 $-280
2013 $117
2012 $-390
2011 $0
2010 $0
2009 $0
Koninklijke Philips Quarterly Other Operating Income or Expenses
(Millions of US $)
2024-09-30 $-10
2024-06-30 $577
2023-06-30 $-3
2023-03-31 $-616
2022-06-30 $28
2021-06-30 $-48
2020-06-30 $110
2019-06-30 $6
2018-06-30 $43
2017-06-30 $-6
2016-12-31 $9
2016-09-30 $7
2016-06-30 $1
2016-03-31 $13
2015-12-31 $54
2015-09-30 $26
2015-06-30 $1
2015-03-31 $16
2014-12-31 $-236
2014-09-30 $-60
2014-06-30 $10
2014-03-31 $5
2013-12-31 $9
2013-09-30 $15
2013-06-30 $69
2013-03-31 $24
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $22.822B $19.503B
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $232.007B 27.90
Boston Scientific (BSX) United States $155.135B 38.84
Stryker (SYK) United States $149.698B 31.30
EssilorLuxottica (ESLOY) France $129.877B 0.00
Medtronic (MDT) Ireland $110.440B 16.12
Lonza Group Ag (LZAGY) Switzerland $48.984B 0.00
Haleon (HLN) United Kingdom $48.101B 27.36
ResMed (RMD) United States $36.449B 27.38
GE HealthCare Technologies (GEHC) United States $33.384B 15.85
Agilent Technologies (A) United States $32.046B 21.17
Terumo (TRUMY) Japan $27.153B 35.27
Insulet (PODD) United States $22.662B 88.96
Zimmer Biomet Holdings (ZBH) United States $19.138B 12.29
Baxter (BAX) United States $15.929B 11.89
Smith & Nephew SNATS (SNN) United Kingdom $12.591B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.030B 0.00
Bio-Rad Laboratories (BIO) United States $6.618B 23.03
Lantheus Holdings (LNTH) United States $5.520B 13.92
Prestige Consumer Healthcare (PBH) United States $4.305B 19.23
Perrigo (PRGO) Ireland $3.614B 9.16
Haemonetics (HAE) United States $3.485B 15.18
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.459B 25.51
Envista Holdings (NVST) United States $3.066B 25.48
QuidelOrtho (QDEL) United States $2.234B 15.36
GN Store Nord (GNNDY) Denmark $2.150B 17.81
LeMaitre Vascular (LMAT) United States $1.882B 42.07
AtriCure (ATRC) United States $1.599B 0.00
Neogen (NEOG) United States $1.424B 18.22
AdaptHealth (AHCO) United States $1.220B 12.38
Kestra Medical Technologies (KMTS) United States $1.220B 0.00
Green Thumb Industries (GTBIF) United States $1.209B 27.19
BioLife Solutions (BLFS) United States $1.045B 0.00
InMode (INMD) Israel $1.023B 9.37
Phibro Animal Health (PAHC) United States $0.966B 12.35
Evolus (EOLS) United States $0.645B 0.00
CeriBell (CBLL) United States $0.636B 0.00
Curaleaf Holdings (CURLF) Canada $0.586B 0.00
Owens & Minor (OMI) United States $0.548B 4.54
Valneva SE (VALN) France $0.516B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.499B 0.00
Tilray Brands (TLRY) Canada $0.443B 0.00
Capricor Therapeutics (CAPR) United States $0.437B 0.00
Surmodics (SRDX) United States $0.401B 0.00
Cresco Labs (CRLBF) United States $0.354B 0.00
SNDL (SNDL) Canada $0.336B 0.00
VAREX IMAGING (VREX) United States $0.325B 11.95
SEMPERIT AG HLD (SEIGY) Austria $0.317B 0.00
Aurora Cannabis (ACB) Canada $0.279B 49.60
Sanara MedTech (SMTI) United States $0.274B 0.00
Verano Holdings (VRNOF) United States $0.271B 0.00
Sanuwave Health (SNWV) United States $0.268B 0.00
Viemed Healthcare (VMD) United States $0.266B 22.47
Cerus (CERS) United States $0.247B 0.00
Canopy Growth (CGC) Canada $0.246B 0.00
ZimVie (ZIMV) United States $0.242B 11.00
Omeros (OMER) United States $0.230B 0.00
Biote (BTMD) United States $0.220B 6.18
Brainsway (BWAY) Israel $0.188B 49.90
High Tide (HITI) Canada $0.187B 0.00
OraSure Technologies (OSUR) United States $0.184B 0.00
Utah Medical Products (UTMD) United States $0.180B 14.51
Quanterix (QTRX) United States $0.175B 0.00
Organigram Global (OGI) Canada $0.166B 0.00
TriSalus Life Sciences (TLSI) United States $0.165B 0.00
FitLife Brands (FTLF) United States $0.136B 16.72
Jin Medical (ZJYL) China $0.129B 0.00
TerrAscend (TSNDF) Canada $0.128B 0.00
Exagen (XGN) United States $0.122B 0.00
MacroGenics (MGNX) United States $0.097B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.090B 0.00
Fonar (FONR) United States $0.084B 10.83
Veru (VERU) United States $0.075B 0.00
Agape ATP (ATPC) $0.075B 0.00
InterCure (INCR) Israel $0.069B 0.00
Jushi Holdings (JUSHF) United States $0.067B 0.00
Zynex (ZYXI) United States $0.066B 0.00
Quipt Home Medical (QIPT) United States $0.065B 0.00
United Health Products (UEEC) United States $0.064B 0.00
Apyx Medical (APYX) United States $0.056B 0.00
Cytosorbents (CTSO) United States $0.052B 0.00
ImmuCell (ICCC) United States $0.048B 0.00
Modular Medical (MODD) United States $0.040B 0.00
United-Guardian (UG) United States $0.038B 13.00
Rockwell Medical (RMTI) United States $0.033B 0.00
Safety Shot (SHOT) United States $0.031B 0.00
Nephros (NEPH) United States $0.023B 30.57
Allurion Technologies (ALUR) United States $0.021B 0.00
INLIF (INLF) $0.019B 0.00
Trinity Biotech (TRIB) Ireland $0.015B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Meihua Medical Technologies (MHUA) China $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00